Home › Carcinoma a cellule squamose della testa e del collo › Ohio › Columbus
Studi clinici su Carcinoma a cellule squamose della testa e del collo a Columbus, OH
20 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a Columbus e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
In reclutamentoFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
In reclutamentoFase 1
- ALX Center 10, Columbus
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
In reclutamentoFase 3
- Ohio State University, Columbus
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
In reclutamentoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
In reclutamentoFase 2
- Research Site, Columbus
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Ohio State University, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
In reclutamentoStudio osservazionale
- Ohio State University, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 2
- Ohio State University, Columbus
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
In reclutamentoFase 2/3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
In reclutamentoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- The Ohio State University, Columbus
SMP-3124LP in Adults With Advanced Solid Tumors
In reclutamentoFase 1/2
- Ohio State University, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Ohio State University, Columbus
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
In reclutamentoFase 1
- Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
In reclutamentoFase 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
In reclutamentoFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
In reclutamento
- Ohio State University Medical Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
In reclutamentoFase 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- The Ohio State University, Columbus
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- New York City, NY39 studi
- Nashville, TN39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Philadelphia, PA26 studi
- Chicago, IL26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- New Haven, CT22 studi
Altri studi a Columbus
- Cancro del polmone non a piccole cellule57 studi
- Cancro al seno40 studi
- Cancro ovarico39 studi
- Cancro (tutti i tipi)38 studi
- Cancro ai polmoni37 studi
- Leucemia mieloide acuta35 studi
- Leucemia linfatica cronica28 studi
- Cancro metastatico27 studi
- Cancro dell'endometrio25 studi
- Cancro alla prostata24 studi
- Mieloma multiplo24 studi
- Cancro colorettale24 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.